Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL
Status:
Unknown status
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Phase II study for treatment of patients with relapsed or primary refractory aggressive B-
cell NHL and anthracycline chemotherapy pretreatment, who received or did not qualify for
autologous stem cell transplantation.